Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms

2012/07/09 by Anil Kumar, Neha Sharma, Amit Gupta +3 · 95 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · Neuroscience · #Atorvastatin #Biochemistry #Calpain Protease Function and Regulation #Chemistry #Disease #Endocrinology #Enzyme #HMG-CoA reductase #Hydroxydopamine #Inflammation #Internal medicine #Medicine #Neuroprotection #Nuclear Receptors and Signaling #Oxidative stress #Parkinson's Disease Mechanisms and Treatments #Parkinson's disease #Pharmacology #Reductase #Simvastatin

paper · doi:10.1016/j.brainres.2012.06.050

published in Brain Research 1471, 13-22 (Elsevier BV)

openalex publication_date 2012/07/09 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/26

Citations

• Tissue sulfhydryl groups

Cited by

• Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease
• Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
• A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets. [europepmc]
• Mitophagy is required for acute cardioprotection by simvastatin. [europepmc]
• Molecular mechanisms underlying the effects of statins in the central nervous system. [europepmc]
• The biomarkers of immune dysregulation and inflammation response in Parkinson disease. [europepmc]
• Increased pro-inflammatory cytokines, glial activation and oxidative stress in the hippocampus after short-term bilateral adrenalectomy. [europepmc]
• Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database. [europepmc]
• Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice. [europepmc]
• The Role of Lipids in Parkinson's Disease. [europepmc]
• Neuroinflammation, Microglia, and Cell-Association during Prion Disease. [europepmc]
• Glucose Homeostasis Is Not Affected in a Murine Model of Parkinson's Disease Induced by 6-OHDA. [europepmc]
• Simvastatin Induces Delayed Apoptosis Through Disruption of Glycolysis and Mitochondrial Impairment in Neuroblastoma Cells. [europepmc]
• A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery. [europepmc]
• Anti-Apoptotic Effects of Carotenoids in Neurodegeneration. [europepmc]
• Acupuncture Treatment Reduces Incidence of Parkinson's Disease in Patients With Depression: A Population-Based Retrospective Cohort Study in Taiwan. [europepmc]
• Effect of statins on post-contrast acute kidney injury: a multicenter retrospective observational study. [europepmc]
• Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal. [europepmc]
• Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson's Disease: A Nationwide Cohort Study. [europepmc]
• Barbigerone Potentially Alleviates Rotenone-Activated Parkinson's Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines. [europepmc]
• Protective Effect of Hirsutidin against Rotenone-Induced Parkinsonism via Inhibition of Caspase-3/Interleukins-6 and 1β. [europepmc]
• Methamphetamine Toxicities and Clinical Management. [europepmc]
• Association Between Statin Use and Mortality in Adults With Parkinson's Disease: A Nationwide Cohort Study. [europepmc]